Forecasted use of analgesic medicine in Norway indicates a significant growth from 2024 to 2028. The unit of measure is Defined Daily Dosage per thousand persons per day. Starting at 101.4 in 2024, we see a year-on-year increase of about 5.1% in 2025, 4.9% in 2026, 4.6% in 2027, and 4.4% in 2028. Comparing changes over the last two years, starting from the actual data available in 2023 up to 2024, shows the overall continued growth trend. The compound annual growth rate over the last five years averages around 4.8% per year.
Future trends to watch for include potential impacts from healthcare policies, demographic changes such as an aging population, and advances in alternative therapies. Understanding these factors will be crucial for stakeholders in adapting to and capitalizing on the expected rising demand for analgesic medicine in Norway.
